Ghoreifi, A., Alshalalfa, M., Jiang, R., Davicioni, E., Spratt, D. E., Karnes, R. J., … Abern, M. R. (2026). IP62-16 PROGNOSTIC SIGNIFICANCE OF HSP90AB1 EXPRESSION IN PROSTATE CANCER: MOLECULAR ASSOCIATIONS AND CLINICAL IMPLICATIONS. In Journal of Urology (Vol. 215). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/01.ju.0001191656.21935.67.16

Ghoreifi, Alireza, Mohammed Alshalalfa, Ruochen Jiang, Elai Davicioni, Daniel E. Spratt, R Jeffrey Karnes, J Todd Purves, Francis M. Hughes, Judd W. Moul, and Michael R. Abern. “IP62-16 PROGNOSTIC SIGNIFICANCE OF HSP90AB1 EXPRESSION IN PROSTATE CANCER: MOLECULAR ASSOCIATIONS AND CLINICAL IMPLICATIONS.” In Journal of Urology, Vol. 215. Ovid Technologies (Wolters Kluwer Health), 2026. https://doi.org/10.1097/01.ju.0001191656.21935.67.16.

Ghoreifi A, Alshalalfa M, Jiang R, Davicioni E, Spratt DE, Karnes RJ, et al. IP62-16 PROGNOSTIC SIGNIFICANCE OF HSP90AB1 EXPRESSION IN PROSTATE CANCER: MOLECULAR ASSOCIATIONS AND CLINICAL IMPLICATIONS. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2026.

Ghoreifi, Alireza, et al. “IP62-16 PROGNOSTIC SIGNIFICANCE OF HSP90AB1 EXPRESSION IN PROSTATE CANCER: MOLECULAR ASSOCIATIONS AND CLINICAL IMPLICATIONS.” Journal of Urology, vol. 215, no. 5S, Ovid Technologies (Wolters Kluwer Health), 2026. Crossref, doi:10.1097/01.ju.0001191656.21935.67.16.

Ghoreifi A, Alshalalfa M, Jiang R, Davicioni E, Spratt DE, Karnes RJ, Purves JT, Hughes FM, Moul JW, Abern MR. IP62-16 PROGNOSTIC SIGNIFICANCE OF HSP90AB1 EXPRESSION IN PROSTATE CANCER: MOLECULAR ASSOCIATIONS AND CLINICAL IMPLICATIONS. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2026.